Key facts
- It has raised $2.0M; the latest was Seed Round ($2.0M) in Jan 2025.
- Notable investors include Foster School Of Business.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Naturacur Wound Healing
- ·The full record, as it builds
Funding rounds
No funding rounds for Naturacur Wound Healing are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Naturacur Wound Healing
Operator of topical wound care technologies designed to support effective healing for acute and chronic wounds. The company offers plant-based hydrogels and barrier creams made with FDA-approved ingredients and free of dyes, scents, and preservatives, enabling healthcare practitioners worldwide to provide low-risk, high-impact wound management.
- Sector
- Healthcare
- HQ
- Auburn, WA, United States
- Founded
- 2022
- Employees
- 2
- Website
- naturacur.com/
- Ownership
- Privately Held (backing)
Naturacur Wound Healing doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Naturacur Wound Healing shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Naturacur Wound Healing in its N-PORT filings yet. We sweep new filings monthly.